Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Setofilm 4mg orodispersible films
0406000S0BEAAAM
|
Setofilm | Ondansetron hydrochloride | Central Nervous System | 106 |
|
Tetrabenazine 25mg/5ml oral suspension
0409030C0AAARAR
|
Tetrabenazine | Tetrabenazine | Central Nervous System | 106 |
|
Latuda 74mg tablets
0402010AIBBACAC
|
Latuda | Lurasidone | Central Nervous System | 104 |
|
Morphine 150mg modified-release capsules
0407020Q0AADWDW
|
Morphine sulfate | Morphine sulfate | Central Nervous System | 104 |
|
Clonazepam 2.5mg/ml drops
0408010F0AADCDC
|
Clonazepam (Systemic) | Clonazepam | Central Nervous System | 103 |
|
Gabapentin 250mg/5ml oral liquid
0408010G0AAAQAQ
|
Gabapentin | Gabapentin | Central Nervous System | 103 |
|
Hydromorphone 2.6mg capsules
040702050AAADAD
|
Hydromorphone hydrochloride | Hydromorphone hydrochloride | Central Nervous System | 103 |
|
Quetiapine 50mg/5ml oral suspension
0402010ABAABEBE
|
Quetiapine | Quetiapine | Central Nervous System | 103 |
|
Victanyl 75micrograms/hour transdermal patches
0407020A0BMACAG
|
Victanyl | Fentanyl | Central Nervous System | 103 |
|
Zeyzelf 9.5mg/24hours twice weekly transdermal patches
0411000E0BLABAG
|
Zeyzelf | Rivastigmine | Central Nervous System | 103 |
|
Midrid 325mg/65mg capsules
0407010ACBBAAAA
|
Midrid | Isometheptene mucate | Central Nervous System | 102 |
|
Nardil 15mg tablets
0403020M0BBAAAA
|
Nardil | Phenelzine sulfate | Central Nervous System | 102 |
|
Oxycodone 5mg/5ml oral solution
0407020ADAAAJAJ
|
Oxycodone hydrochloride | Oxycodone hydrochloride | Central Nervous System | 101 |
|
Zopiclone 7.5mg/5ml oral suspension
0401010Z0AAALAL
|
Zopiclone | Zopiclone | Central Nervous System | 101 |
|
Dacepton 30mg/3ml solution for injection cartridges
0409010ACBBAAAA
|
Dacepton | Apomorphine hydrochloride hemihydrate | Central Nervous System | 100 |
|
Erastig 13.3mg/24hours transdermal patches
0411000E0BFACAI
|
Erastig | Rivastigmine | Central Nervous System | 100 |
|
Palexia SR 250mg tablets
0407020AGBBAGAG
|
Palexia | Tapentadol | Central Nervous System | 100 |
|
Sunveniz XL 75mg tablets
0403040W0BXAAAJ
|
Sunveniz | Venlafaxine | Central Nervous System | 100 |
|
Morphine 1mg orodispersible tablets sugar free
0407020Q0AAGGGG
|
Morphine sulfate | Morphine sulfate | Central Nervous System | 99 |
|
Ritalin XL 30mg capsules
0404000M0BBAEAV
|
Ritalin | Methylphenidate hydrochloride | Central Nervous System | 99 |
|
Tramacet 37.5mg/325mg effervescent tablets
040702040BFABBA
|
Tramacet | Tramadol hydrochloride | Central Nervous System | 99 |
|
Asenapine 10mg sublingual tablets sugar free
0402030R0AAAAAA
|
Asenapine | Asenapine | Central Nervous System | 98 |
|
Axalid 300mg capsules
0408010AEBFAHAG
|
Axalid | Pregabalin | Central Nervous System | 98 |
|
Pitolisant 18mg tablets
0404000W0AAAAAA
|
Pitolisant hydrochloride | Pitolisant hydrochloride | Central Nervous System | 98 |
|
Sabril 500mg granules for oral solution sachets
0408010X0BBABAF
|
Sabril | Vigabatrin | Central Nervous System | 98 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.